Dramatic Enhancement of Quantum Cutting in Lanthanide-Doped Nanocrystals Photosensitized with an Aggregation-Induced Enhanced Emission Dye

Applications of multiphoton processes in lanthanide-doped nanophosphors (NPs) are often limited by relatively weak and narrow absorbance. Here, the concept of an ultimate photosensitization by aggregation-induced enhanced emission (AIEE) dyes to overcome this limitation is introduced. Because AIEE dyes do not suffer from concentration quenching, they can fully cover the NP surface at high density to maximize absorbance while passivating the surface. This concept is applied to multiphoton down-conversion by quantum cutting. Specifically, coating Yb³⁺/Tb³⁺-doped NPs with an AIEE dye designed for efficient energy transfer and attachment to the NPs produces a 2260-fold enhancement of multiphoton down-conversion by quantum cutting with remarkable photostability. In a prototypical application, the quantum cutting of UV photons to near-infrared photons that are matched to the band gap of a silicon solar cell produces an average 4% increase in efficiency under concentrated solar illumination. This provides a general strategy for NP photosensitization that can be applied to both multiphoton up- and down-conversion.

Upconversion in photodynamic therapy: plumbing the depths

Photodynamic therapy (PDT) involves the combination of non-toxic dyes called photosensitizers (PS) and harmless visible light that interact with ambient oxygen to give reactive oxygen species (ROS) that can damage biomolecules and kill cells. PDT has mostly been developed as a cancer therapy but can also be used as an antimicrobial approach against localized infections. However even the longest wavelength used for exciting PS (in the 700 nm region) has relatively poor tissue penetration, and many PS are much better excited by blue and green light. Therefore upconversion nanoparticles (UCNPs) have been investigated in order to allow deeper-penetrating near-infrared light (980 nm or 810 nm) to be used for PDT. NaYF4 nanoparticles doped with Yb3+ and Er3+ or with Tm3+ and Er3+ have been attached to PS either by covalent conjugation, or by absorption to the coating or shell (used to render the UCNPs biocompatible). Forster resonance energy transfer to the PS then allows NIR light energy to be transduced into ROS leading to cell killing and tumor regression. Some studies have experimentally demonstrated the deep tissue advantage of UCNP-PDT. Recent advances have included dye-sensitized UCNPs and UCNPs coupled to PS, and other potentially synergistic drug molecules or techniques. A variety of bioimaging modalities have also been combined with upconversion PDT. Further studies are necessary to optimize the drug-delivery abilities of the UCNPs, improve the quantum yields, allow intravenous injection and tumor targeting, and ensure lack of toxicity at the required doses before potential clinical applications.

An 800 nm driven NaErF4@NaLuF4 upconversion platform for multimodality imaging and photodynamic therapy

Multimodality imaging-guided therapy based on lanthanide-doped upconversion nanoparticles (UCNPs) has become a trend in cancer theranostics. However, the overheating effect of 980 nm excitation in photodynamic therapy (PDT) and the difficulties in optimizing multimodality imaging integration within a single particle are still challenges. Herein, 800 nm driven NaErF4@NaLuF4 UCNPs have been explored for optimized multimodality imaging and near-infrared (NIR) triggered PDT. Our results confirmed that the optimal ∼5 nm shell thickness can well balance the enhancement of upconversion luminescence and the attenuation of energy transfer efficiency from Er3+ towards a photosensitizer, to achieve efficient production of singlet oxygen (1O2) for PDT under 800 nm excitation. Furthermore, the as-obtained NaErF4@NaLuF4 UCNPs showed effective and applicable performance for upconversion luminescence (UCL) imaging, X-ray computed tomography (CT), and high-field T2 magnetic resonance imaging (MRI). This nanomaterial can serve as an excellent theranostic agent for multimodality imaging and image-guided therapy.

Graphene Oxide-Upconversion Nanoparticle Based Portable Sensors for Assessing Nutritional Deficiencies in Crops

The development of innovative technologies to rapidly detect biomarkers associated with nutritional deficiencies in crops is highly relevant to agriculture and thus could impact the future of food security. Zinc (Zn) is an important micronutrient in plants, and deficiency leads to poor health, quality, and yield of crops. We have developed portable sensors, based on graphene oxide and upconversion nanoparticles, which could be used in the early detection of Zn deficiency in crops, sensing mRNAs encoding members of the ZIP-transporter family in crops. ZIPs are membrane transport proteins, some of which are up-regulated at the early stages of Zn deficiency, and they are part of the biological mechanism by which crops respond to nutritional deficiency. The principle of these sensors is based on the intensity of the optical output resulting from the interaction of oligonucleotide-coated upconversion nanoparticles and graphene oxide in the absence or presence of a specific oligonucleotide target. The sensors can reliably detect mRNAs in RNA extracts from plants using a smartphone camera. Our work introduces the development of accurate and highly sensitive sensors for use in the field to determine crop nutrient status and ultimately facilitate economically important nutrient management decisions.

Upconversion nanocomposite for programming combination cancer therapy by precise control of microscopic temperature

Combinational administration of chemotherapy (CT) and photothermal therapy (PTT) has been widely used to treat cancer. However, the scheduling of CT and PTT and how it will affect the therapeutic efficacy has not been thoroughly investigated. The challenge is to realize the sequence control of these two therapeutic modes. Herein, we design a temperature sensitive upconversion nanocomposite for CT-PTT combination therapy. By monitoring the microscopic temperature of the nanocomposite with upconversion luminescence, photothermal effect can be adjusted to achieve thermally triggered combination therapy with a sequence of CT, followed by PTT. We find that CT administered before PTT results in better therapeutic effect than other administration sequences when the dosages of chemodrug and heat are kept at the same level. This work proposes a programmed method to arrange the process of combination cancer therapy, which takes full advantage of each therapeutic mode and contributes to the development of new cancer therapy strategies.

The combination of chemo and photothermal therapy is widely used to treat cancer but control of chemo and thermal effects is needed for optimized treatment. Here, the authors describe an upconversion nanoparticle which can be used for controlled sequential treatment by controlling laser power.

A novel near-infrared nanomaterial with high quantum efficiency and its applications in real time in vivo imaging

Fluorescence imaging signal is severely limited by the quantum efficiency and emission wavelength. To overcome these challenges, novel NIR-emitting K₅NdLi₂F₁₀ nanoparticles under NIR excitation was introduced as fluorescence imaging probe for the first time. The photostability of K₅NdLi₂F₁₀ nanoparticles in the water, phosphate buffer saline, fetal bovine serum and living mice was investigated. The fluorescence signal was detected with depths of 3.5 and 2.0 cm in phantom and pork tissue, respectively. Fluorescence spectrum with a significant signal-to-background ratio of 10:1 was captured in living mice. Moreover, clear NIR images were virtualized for the living mice after intravenous injection. The imaging ability of nanoparticles in tumor-beard mice were evaluated, the enrichment of K₅NdLi₂F₁₀ nanoparticles in tumor site due to the enhanced permeability and retention effect was confirmed. The systematic studies of toxicity, bio-distribution and in-vivo dynamic imaging suggest that these materials give high biocompatibility and low toxicity. These NIR-emitting nanoparticles with high quantum efficiency, high penetration and low toxicity might facilitate tumor identification in deep tissues more sensitively.

Recent Progress in Upconversion Photodynamic Therapy

Photodynamic therapy (PDT) is a minimally invasive cancer modality that combines a photosensitizer (PS), light, and oxygen. Introduction of new nanotechnologies holds potential to improve PDT performance. Upconversion nanoparticles (UCNPs) offer potentially advantageous benefits for PDT, attributed to their distinct photon upconverting feature. The ability to convert near-infrared (NIR) light into visible or even ultraviolet light via UCNPs allows for the activation of nearby PS agents to produce singlet oxygen, as most PS agents absorb visible and ultraviolet light. The use of a longer NIR wavelength permits light to penetrate deeper into tissue, and thus PDT of a deeper tissue can be effectively achieved with the incorporation of UCNPs. Recent progress in UCNP development has generated the possibility to employ a wide variety of NIR excitation sources in PDT. Use of UCNPs enables concurrent strategies for loading, targeting, and controlling the release of additional drugs. In this review article, recent progress in the development of UCNPs for PDT applications is summarized.

Dye-Sensitized Downconversion

Splitting one high-energy photon into two lower energy photons through downconversion has been demonstrated for a variety of combinations of rare earth (RE) ions. However, the low absorption cross section of RE³⁺ 4f-4f transitions hampers practical application. Therefore, enhancing the absorption by sensitization is crucial. We demonstrate efficient dye-sensitized downconversion using a strong blue/UV absorbing Coumarin dye to sensitize downconversion of the Pr³⁺-Yb³⁺ couple in NaYF₄ nanocrystals (NCs). Luminescence spectra and lifetime measurements reveal Förster resonant energy transfer (FRET) from Coumarin to Pr³⁺ in NaYF₄:Pr³⁺Yb³⁺ NCs, followed by downconversion, resulting in Yb³⁺ IR emission with ∼30 times enhancement. The present study demonstrates the feasibility of dye-sensitized downconversion as a promising strategy to engineer strongly absorbing downconversion NCs to enhance the efficiency of photovoltaic cells.

Highly luminescent, biocompatible ytterbium(iii) complexes as near-infrared fluorophores for living cell imaging

We report three synthetic methods to prepare biocompatible Yb³⁺ complexes, which displayed high NIR luminescence with quantum yields up to 13% in aqueous media. This renders β-fluorinated Yb³⁺ porphyrinoids a new class of NIR probes for living cell imaging including time-resolved fluorescence lifetime imaging.

Herein, we report the design and synthesis of biocompatible Yb³⁺ complexes for near-infrared (NIR) living cell imaging. Upon excitation at either the visible (Soret band) or red region (Q band), these β-fluorinated Yb³⁺ complexes display high NIR luminescence (quantum yields up to 23% and 13% in dimethyl sulfoxide and water, respectively) and have higher stabilities and prolonged decay lifetimes (up to 249 μs) compared to the β-non-fluorinated counterparts. This renders the β-fluorinated Yb³⁺ complexes as a new class of biological optical probes in both steady-state imaging and time-resolved fluorescence lifetime imaging (FLIM). NIR confocal fluorescence images showed strong and specific intracellular Yb³⁺ luminescence signals when the biocompatible Yb³⁺ complexes were uptaken into the living cells. Importantly, FLIM measurements showed an intracellular lifetime distribution between 100 and 200 μs, allowing an effective discrimination from cell autofluorescence, and afforded high signal-to-noise ratios as firstly demonstrated in the NIR region. These results demonstrated the prospects of NIR lanthanide complexes as biological probes for NIR steady-state fluorescence and time-resolved fluorescence lifetime imaging.

Current progress in the controlled synthesis and biomedical applications of ultrasmall (<10 nm) NaREF4 nanoparticles

The design and fabrication of rare earth upconversion nanoparticle (UCNP)-based nanomedical platforms have evoked increasing interest. However, their bio-safety is always the most worrisome problem. Most nanoparticles can accumulate in the internal organs, leading to acute toxicity, a long-term inflammatory response, or even fibrosis and cancer. In contrast, ultrasmall (sub-10 nm) nanoparticles have minimal safety risk because they can escape from macrophages, pass biological barriers, and be easily degraded or excreted from the body. In this review, we mainly introduce new progress in preparation strategies, imaging and drug delivery with regards to ultrasmall UCNPs, with an emphasis on rare earth fluorides, NaREF₄. Finally, we discuss the future outlook and challenges relating to ultrasmall UCNPs.

Enabling Photon Upconversion and Precise Control of Donor-Acceptor Interaction through Interfacial Energy Transfer

Upconverting materials have achieved great progress in recent years, however, it remains challenging for the mechanistic research on new upconversion strategy of lanthanides. Here, a novel and efficient strategy to realize photon upconversion from more lanthanides and fine control of lanthanide donor-acceptor interactions through using the interfacial energy transfer (IET) is reported. Unlike conventional energy-transfer upconversion and recently reported energy-migration upconversion, the IET approach is capable of enabling upconversions from Er3+, Tm3+, Ho3+, Tb3+, Eu3+, Dy3+ to Sm3+ in NaYF4- and NaYbF4-based core-shell nanostructures simultaneously. Applying the IET in a Nd-Yb coupled sensitizing system can also enable the 808/980 nm dual-wavelength excited upconversion from a single particle. More importantly, the construction of IET concept allows for a fine control and manipulation of lanthanide donor-acceptor interactions and dynamics at the nanometer-length scale by establishing a physical model upon an interlayer-mediated nanostructure. These findings open a door for the fundamental understanding of the luminescence dynamics involving lanthanides at nanoscale, which would further help conceive new scientific concepts and control photon upconversion at a single lanthanide ion level.

Photo-Induced Electron Transfer-Based Versatile Platform with G-Quadruplex/Hemin Complex as Quencher for Construction of DNA Logic Circuits

G-quadruplex has been developed as an innovator for analytical chemistry and biomedicine due to its vibrant binding activity, structural polymorphism, and critical roles in biological regulation. Herein, a simple but versatile platform was obtained by integrating split G-quadruplex and fluorophore into a molecular beacon, where the photoinduced electron transfer could occur when the fluorophore approached the preformed G-quadruplex/hemin complexes. Such design subtly combined the G4 disruption-induced fluorescent turn-on strategy and the photoinduced electron transfer property into one platform for constructing the logic circuits. On the basis of such a universal platform, a series of binary logic gates (OR, INHIBIT, AND, and XOR), a combinatorial gate (INHIBIT-OR), and even a complex logic operation for discrimination of multiples of three from natural numbers less than ten have been successfully achieved only by employing such platform as work unit and single-strand DNAs as inputs. The set-reset function of this platform could be realized by alternatively introducing blocking and releasing strands. In addition, this platform could operate in a biological matrix stably and precisely. Therefore, such a universal platform lays the foundation for complicating the logic systems, realizing the biocomputing and also points out a new direction for target detection.

Core-Shell-Shell Upconversion Nanoparticles with Enhanced Emission for Wireless Optogenetic Inhibition

Recent advances in upconversion technology have enabled optogenetic neural stimulation using remotely applied optical signals, but limited success has been demonstrated for neural inhibition by using this method, primarily due to the much higher optical power and more red-shifted excitation spectrum that are required to work with the appropriate inhibitory opsin proteins. To overcome these limitations, core-shell-shell upconversion nanoparticles (UCNPs) with a hexagonal phase are synthesized to optimize the doping contents of ytterbium ions (Yb³⁺) and to mitigate Yb-associated concentration quenching. Such UCNPs' emission contains an almost three-fold enhanced peak around 540-570 nm, matching the excitation spectrum of a commonly used inhibitory opsin protein, halorhodopsin. The enhanced UCNPs are utilized as optical transducers to develop a fully implantable upconversion-based device for in vivo tetherless optogenetic inhibition, which is actuated by near-infrared (NIR) light irradiation without any electronics. When the device is implanted into targeted sites deep in the rat brain, the electrical activity of the neurons is reliably inhibited with NIR irradiation and restores to normal level upon switching off the NIR light. The system is further used to perform tetherless unilateral inhibition of the secondary motor cortex in behaving mice, achieving control of their motor functions. This study provides an important and useful supplement to the upconversion-based optogenetic toolset, which is beneficial for both basic and translational neuroscience investigations.

Recent progress in upconversion luminescence nanomaterials for biomedical applications

This review focuses on the biomedical applications of upconversion luminescence nanomaterials, including lanthanide-doped inorganic nanocrystals and TTA-based UCNPs.

Near infrared harvesting dye-sensitized solar cells enabled by rare-earth upconversion materials

Dye-sensitized solar cells (DSSCs) have been deemed as promising alternatives to silicon solar cells for the conversion of clean sunlight energy into electricity.

A specific HeLa cell-labelled and lysosome-targeted upconversion fluorescent probe: PEG-modified Sr2YbF7:Tm3+

In this study, water-soluble PEG-modified Sr₂YbF₇:Tm³⁺ was prepared conveniently by a one-pot solvothermal method, where the molar ratio of Sr²⁺ to Yb³⁺ was controlled between 3 : 2 and 1 : 1. The optimum red-light emission at 677-699 nm was modulated via 0.7% Tm³⁺ doped under irradiation at 980 nm. Interestingly, biological experimental results showed that the PEG-modified Sr₂YbF₇:Tm³⁺ with low toxicity, excellent cell membrane permeability and high photostability can not only distinguish HeLa cells from mouse embryonic fibroblasts but also target the subcellular organelle lysosome in HeLa cells; therefore it can be anticipated that the as-prepared material would be a potential tool for cancer diagnosis.

Controlled Synthesis of Monodisperse Hexagonal NaYF₄:Yb/Er Nanocrystals with Ultrasmall Size and Enhanced Upconversion Luminescence

The ability to synthesize upconversion nanocrystals (UCNCs) with tailored upconversion luminescence and controlled size is of great importance for biophotonic applications. However, until now, limited success has been met to prepare bright, ultrasmall, and monodispersed β-NaYF₄:Yb³⁺/Er³⁺ UCNCs. In this work, we report on a synthetic method to produce monodisperse hexagonal NaYF₄:Yb³⁺/Er³⁺ nanocrystals of ultrasmall size (5.4 nm) through a precise control of the reaction temperature and the ratio of Na⁺/Ln³⁺/F⁻. We determined the optimum activator concentration of Er³⁺ to be 6.5 mol % for these UCNCs, yielding about a 5-fold higher upconversion luminescence (UCL) intensity than the commonly used formula of NaYF₄:30% Yb³⁺/2% Er³⁺. Moreover, a thin epitaxial shell (thickness, 1.9 nm) of NaLnF₄ (Ln = Y, Gd, Lu) was grown onto these ultrasmall NaYF₄:Yb³⁺/Er³⁺ NCs, enhancing its UCL by about 85-, 70- and 50-fold, respectively. The achieved sub-10-nm core and core–shell hexagonal NaYF₄:Yb³⁺/Er³⁺ UCNCs with enhanced UCL have strong potential applications in bioapplications such as bioimaging and biosensing.